ID   MCF-7 PRODH KO
AC   CVCL_B7K1
SY   MCF7POX-KO; PRODH/POX CRISPR/Cas9 knockout MCF7
DR   cancercelllines; CVCL_B7K1
DR   Wikidata; Q112930089
RX   PubMed=35409177;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9453; PRODH.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=35409177; DOI=10.3390/ijms23073813; PMCID=PMC8998922;
RA   Kazberuk A., Chalecka M., Palka J., Bielawska K., Surazynski A.;
RT   "NSAIDs induce proline dehydrogenase/proline oxidase-dependent and
RT   independent apoptosis in MCF7 breast cancer cells.";
RL   Int. J. Mol. Sci. 23:3813.1-3813.18(2022).
//